328 results
Page 12 of 17
8-K
lgap36ur
3 Jun 11
Departure of Directors or Certain Officers
12:00am
8-K
EX-99.1
4nuog2i6dxjjq8
23 May 11
Human Application of Novel, Synthetic Biology Approach to be Presented at 2011 ASCO Annual Meeting
12:00am
8-K
EX-99.1
h1z vhbmttxyieejxw
19 May 11
Other Events
12:00am
8-K
EX-99.1
6ezgc oa1b9
1 Mar 11
ZIOPHARM Reports Fourth Quarter and Full Year 2010 Financial Results
12:00am
424B5
aiug7jq 91j7by1p9
7 Feb 11
Prospectus supplement for primary offering
12:00am
8-K
562mb
7 Feb 11
Ziopharm Prices Public Offering of Common Stock
12:00am
8-K
EX-1.1
flw94n3jak
7 Feb 11
Ziopharm Prices Public Offering of Common Stock
12:00am
8-K
v3u3hm
3 Feb 11
Ziopharm Announces Proposed Public Offering of Common Stock
12:00am
424B5
618zj47hoyhl9xt
2 Feb 11
Prospectus supplement for primary offering
12:00am
8-K
EX-99.1
arwfsg8wa fcdjer8
26 Jan 11
ZIOPHARM Receives Positive Opinion for Orphan Drug Designation for Darinaparsin from European Medicines Agency
12:00am
8-K
t5kaxo
12 Jan 11
ZIOPHARM Oncology and Intrexon Announce Worldwide Partnership for Synthetic Biology DNA-based Oncology Therapeutics
12:00am
8-K
EX-99.1
gnx514umyrm12
12 Jan 11
ZIOPHARM Oncology and Intrexon Announce Worldwide Partnership for Synthetic Biology DNA-based Oncology Therapeutics
12:00am
8-K
EX-10.1
npve81lj
12 Jan 11
ZIOPHARM Oncology and Intrexon Announce Worldwide Partnership for Synthetic Biology DNA-based Oncology Therapeutics
12:00am
8-K
EX-99.1
7bn6c2gni05pc1pw5ebc
5 Jan 11
ZIOPHARM Oncology Announces First Patient Dosed in Phase I Study of
12:00am
8-K
EX-99.1
oqt44n9lf0
4 Nov 10
Ziopharm Reports Third Quarter Financial Results
12:00am